# Codevelopment of Two or More New Investigational Drugs for Use in Combination - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/codevelopment-of-two-or-more-new-investigational-drugs-for-use-in-combination/6a704e0b-f05e-4e65-91b9-7d60ac493505

> FDA guidance document: Codevelopment of Two or More New Investigational Drugs for Use in Combination. Issue date: June 14, 2013. Get complete insights and analysis.

---

## Details

- Title: Codevelopment of Two or More New Investigational Drugs for Use in Combination
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2013-06-14
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2010-D-0616">FDA-2010-D-0616</a>

## Related Documents

- [Abuse-Deterrent Opioids-Evaluation and Labeling](https://www.globalkeysolutions.net/guidances/guidance-document/abuse-deterrent-opioids-evaluation-and-labeling/cd0f4ddf-e4fc-4694-a929-33733fb8e8db)
- [Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/investigational-new-drug-applications-for-positron-emission-tomography-pet-drugs/c3d2d63b-b192-4684-b9ea-880c5065d37b)
- [Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation](https://www.globalkeysolutions.net/guidances/guidance-document/tablet-scoringnomenclature-labeling-and-data-for-evaluation/d4b6bb69-1a24-4ebd-be2e-a80b08473b39)